Carter Keller is a biotech entrepreneur and co-founder of GigaGen and GigaMune, specializing in the development of therapeutics for cancer and infectious diseases. Keller has held leadership roles in various biotechnology companies, directing marketing and product launches, including a successful entry into an orphan oncology indication. With experience raising over $62 million for drug development, Keller currently serves as SVP at Grifols, focusing on innovative antibody therapeutic development. Keller holds an MBA from Haas School of Business and a BSE in Chemical Engineering from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices